Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Lommatzsch, M; Criée, CP; de, Jong, CCM; Gappa, M; Geßner, C; Gerstlauer, M; Hämäläinen, N; Haidl, P; Hamelmann, E; Horak, F; Idzko, M; Ignatov, A; Koczulla, AR; Korn, S; Köhler, M; Lex, C; Meister, J; Milger-Kneidinger, K; Nowak, D; Pfaar, O; Pohl, W; Preisser, AM; Rabe, KF; Riedler, J; Schmidt, O; Schreiber, J; Schuster, A; Schuhmann, M; Spindler, T; Taube, C; Christian, Virchow, J; Vogelberg, C; Vogelmeier, CF; Wantke, F; Windisch, W; Worth, H; Zacharasiewicz, A; Buhl, R, , Weitere, beteiligte, Wissenschaftliche, Fachgesellschaften, und, Organisationen:Deutsche, Atemwegsliga, e. V.Deutsche, Gesellschaft, für, Arbeitsmedizin, und, Umweltmedizin, e. V.Deutsche, Gesellschaft, für, Allergologie, und, klinische, Immunologie, e. V.Deutsche, Gesellschaft, für, Gynäkologie, und, Geburtshilfe, e. V.Deutsche, Gesellschaft, für, Rehabilitationswissenschaften, e. V.Gesellschaft, für, Pädiatrische, Allergologie, und, Umweltmedizin, e. V.Gesellschaft, für, Pädiatrische, Pneumologie, e. V.Bundesverband, der, Pneumologen, Schlaf-, und, BeatmungsmedizinerÖsterreichische, Gesellschaft, für, Kinder-, und, JugendheilkundeÖsterreichische, Gesellschaft, für, PneumologieDeutsche, Patientenliga, Atemwegserkrankungen, e. V..
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e. V.].
Pneumologie. 2023; 77(8):461-543
Doi: 10.1055/a-2070-2135
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Milger-Kneidinger Katrin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The management of asthma has fundamentally changed during the past decades. The present guideline for the diagnosis and treatment of asthma was developed for respiratory specialists who need detailed and evidence-based information on the new diagnostic and therapeutic options in asthma. The guideline shows the new role of biomarkers, especially blood eosinophils and fractional exhaled NO (FeNO), in diagnostic algorithms of asthma. Of note, this guideline is the first worldwide to announce symptom prevention and asthma remission as the ultimate goals of asthma treatment, which can be achieved by using individually tailored, disease-modifying anti-asthmatic drugs such as inhaled steroids, allergen immunotherapy or biologics. In addition, the central role of the treatment of comorbidities is emphasized. Finally, the document addresses several challenges in asthma management, including asthma treatment during pregnancy, treatment of severe asthma or the diagnosis and treatment of work-related asthma.
- Find related publications in this database (using NLM MeSH Indexing)
- Female - administration & dosage
- Pregnancy - administration & dosage
- Humans - administration & dosage
- Nitric Oxide - administration & dosage
- Asthma - therapy, drug therapy
- Anti-Asthmatic Agents - therapeutic use
- Biomarkers - administration & dosage
- Desensitization, Immunologic - administration & dosage